245 related articles for article (PubMed ID: 21168865)
1. Is the screening method of sacral neuromodulation a prognostic factor for long-term success?
Marcelissen T; Leong R; Serroyen J; van Kerrebroeck P; de Wachter S
J Urol; 2011 Feb; 185(2):583-7. PubMed ID: 21168865
[TBL] [Abstract][Full Text] [Related]
2. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
3. Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey.
Leong RK; Marcelissen TA; Nieman FH; De Bie RA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2011 Feb; 185(2):588-92. PubMed ID: 21168881
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
5. Medium-term experience of sacral neuromodulation by tined lead implantation.
Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
[TBL] [Abstract][Full Text] [Related]
6. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
7. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?
Peters KM; Killinger KA; Boura JA
Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596
[TBL] [Abstract][Full Text] [Related]
8. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
Chartier-Kastler E
BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
[No Abstract] [Full Text] [Related]
9. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.
van Voskuilen AC; Oerlemans DJ; Weil EH; de Bie RA; van Kerrebroeck PE
Eur Urol; 2006 Feb; 49(2):366-72. PubMed ID: 16413105
[TBL] [Abstract][Full Text] [Related]
10. The effect of pulse rate changes on the clinical outcome of sacral neuromodulation.
Marcelissen TA; Leong RK; Nieman FH; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2011 May; 185(5):1781-5. PubMed ID: 21420118
[TBL] [Abstract][Full Text] [Related]
11. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.
Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG
BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157
[TBL] [Abstract][Full Text] [Related]
12. [Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study].
Ferhi K; Miaadi N; Tanneau Y; Leroi AM; Sibert L; Grise P
Prog Urol; 2008 Mar; 18(3):160-6. PubMed ID: 18472068
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for successful percutaneous tibial nerve stimulation.
van Balken MR; Vergunst H; Bemelmans BL
Eur Urol; 2006 Feb; 49(2):360-5. PubMed ID: 16359781
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence.
Govaert B; Melenhorst J; Nieman FH; Bols EM; van Gemert WG; Baeten CG
Dis Colon Rectum; 2009 Oct; 52(10):1688-94. PubMed ID: 19966599
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
[TBL] [Abstract][Full Text] [Related]
16. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
[TBL] [Abstract][Full Text] [Related]
17. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
Daniels DH; Powell CR; Braasch MR; Kreder KJ
Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
[TBL] [Abstract][Full Text] [Related]
18. [Sacral neuromodulation and sexuality].
Gamé X
Prog Urol; 2008 Mar; 18(3):167. PubMed ID: 18472069
[No Abstract] [Full Text] [Related]
19. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
